Therapeutic Nuclear Medicine Market Size by Type, Application, Procedural Volume Assessment and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2030
4.7%
CAGR (2024-2030)
5.11 USD Bn.
Market Size
330
Report Pages
122
Market Tables
Overview
The Therapeutic Nuclear Medicine Market size was valued at USD 5.11 Billion in 2023 and the total Therapeutic Nuclear Medicine revenue is expected to grow at a CAGR of 4.7% from 2024 to 2030, reaching nearly USD 7.05 Billion.
The report study has analyzed the revenue impact of COVID 19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
To know about the Research Methodology :- Request Free Sample Report
Nuclear medicines or radiopharmaceuticals are regular medications that are utilized for the diagnosis of dysfunctions in human body tissue. Nuclear medicines are utilized for both diagnostic and remedial purposes and there are 30+ explicit radiopharmaceuticals utilized by medical specialists. Different types of nuclear medicines are valuable in treating cancer, neurological issues, gastrointestinal, and different diseases.
Growing rate of disease is one of the main factors expected to boost the market for nuclear medicine. For example, as indicated by WHO, in 2019, around the world there were an expected 9.6 million deaths because of cancer. Moreover, the expanding prevalence of cardiovascular diseases is adding to the growth of the nuclear medicine market.
Cancer causes nearly one out of six deaths over the world and the population experiencing different type of it is expanding continuously because of lifestyle changes involving tobacco and liquor, low intake of leafy foods, and absence of physical activity.
Advances in radiotracers, approach of alpha radio immunotherapy based focused on cancer treatments, and ventures by means of public and private partnerships to change symptomatic measures are some of different components expected to drive the interest in radiopharmaceuticals near future. On the other hand, significantly shorter half-existence of radiopharmaceuticals, generously significant expense of these specific medicines are some of the restraints impeding the market from achieving more prominent benefit.
North America dominated the general market as far as income in 2019 because of high interests in R&D and backing of government towards the utilization of medical isotopes which are driving the market. Likewise, the large share can be ascribed to the advancement of novel technologies for radioisotope production, government funding, and company initiatives in the region. The Europe market additionally held a large share in the global market in 2019.
The market in Asia Pacific is projected to grow significantly during the forecast period. Rising geriatric population and awareness about nuclear medicines and molecular imaging are adding to the growth of the radiopharmaceuticals market in this region. Besides, this region is focusing in on the improvement of radiopharmaceuticals for the diagnosis and treatment of different diseases.
The objective of the report is to present a comprehensive analysis of the Therapeutic Nuclear Medicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Therapeutic Nuclear Medicine Market dynamics, structure by analyzing the market segments and projects the Therapeutic Nuclear Medicine Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Therapeutic Nuclear Medicine Market make the report investor’s guide.
Scope of the Therapeutic Nuclear Medicine Market: Inquire before buying
| Global Therapeutic Nuclear Medicine Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | USD 5.11 Bn. |
| Forecast Period 2024 to 2030 CAGR: | 4.7% | Market Size in 2030: | USD 7.05 Bn. |
| Segments Covered: | by Type | Diagnostic Nuclear Medicine Therapeutic Nuclear Medicine Brachytherapy Isotopes |
|
| by Application | SPECT Applications PET Applications Therapeutic Applications |
||
| by Procedural Volume Assessment | Diagnostic Procedures Therapeutic Procedures |
||
Therapeutic Nuclear Medicine Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Key players operating in Therapeutic Nuclear Medicine Market
1. Cardinal Health
2. GE Healthcare
3. Curium
4. Lantheus Medical Imaging
5. Bayer AG
6. Bracco Imaging
7. Eczacýbaþý-Monrol Nuclear Products (Turkey)
8. Nordion (Canada)
9. Advanced Accelerator Applications (France)
10.NTP Radioisotopes (South Africa)
11.JSC Isotope (Russia)
12.NorthStar Medical Radioisotopes (US)
13.Eckert & Ziegler (Germany)
14.Jubilant DraxImage (Canada)
15.PharmaLogic (US)
16.Institute of Isotopes Co., Ltd. (Hungary)
17.Sinotau Pharmaceuticals (China)
18.Isotopia Molecular Imaging Limited (Israel)
19.SHINE Medical Technologies (US)
20.Global Medical Solutions (US)
Frequently Asked Questions:
1] What segments are covered in the Global Therapeutic Nuclear Medicine Market report?
Ans. The segments covered in the Market report are based on Application, Type, and Procedural Volume.
2] Which region is expected to hold the highest share in the Global Market?
Ans. The North American region is expected to hold the highest share in Market.
3] What is the market size of the Global Market by 2030?
Ans. The market size of the Global Market by 2030 is expected to reach USD 7.05 Bn.
4] What is the forecast period for the Global Market?
Ans. The forecast period for the Market is 2024-2030.
5] What was the Global Therapeutic Nuclear Medicine Market size in 2023?
Ans: The Global Therapeutic Nuclear Medicine Market size was USD 5.11 Billion in 2023.
Table of Contents
Therapeutic Nuclear Medicine Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Therapeutic Nuclear Medicine Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Therapeutic Nuclear Medicine Market Analysis and Forecast
6.1. Therapeutic Nuclear Medicine Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
7.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Type
7.5. Therapeutic Nuclear Medicine Market Analysis, By Type
7.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Type
8. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Procedural Volume Assessment
8.1. Introduction and Definition
8.2. Key Findings
8.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
8.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Procedural Volume Assessment
8.5. Therapeutic Nuclear Medicine Market Analysis, By Procedural Volume Assessment
8.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Procedural Volume Assessment
9. Therapeutic Nuclear Medicine Market Analysis and Forecast, By Application
9.1. Introduction and Definition
9.2. Key Findings
9.3. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
9.4. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, By Application
9.5. Therapeutic Nuclear Medicine Market Analysis, By Application
9.6. Therapeutic Nuclear Medicine Market Attractiveness Analysis, By Application
10. Therapeutic Nuclear Medicine Market Analysis, by Region
10.1. Therapeutic Nuclear Medicine Market Value Share Analysis, by Region
10.2. Therapeutic Nuclear Medicine Market Size (US$ Bn) Forecast, by Region
11. North America Therapeutic Nuclear Medicine Market Analysis
11.1. Key Findings
11.2. North America Therapeutic Nuclear Medicine Market Overview
11.3. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
11.4. North America Therapeutic Nuclear Medicine Market Forecast, By Type
11.4.1. Diagnostic Nuclear Medicine
11.4.2. Therapeutic Nuclear Medicine
11.4.3. Brachytherapy Isotopes
11.5. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
11.6. North America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
11.6.1. Diagnostic Procedures
11.6.2. Therapeutic Procedures
11.7. North America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
11.8. North America Therapeutic Nuclear Medicine Market Forecast, By Application
11.8.1. SPECT Applications
11.8.2. PET Applications
11.8.3. Therapeutic Applications
11.9. North America Therapeutic Nuclear Medicine Market Value Share Analysis, by Country
11.9.1. U.S.
11.9.2. Canada
11.10. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
11.11. U.S. Therapeutic Nuclear Medicine Market Forecast, By Type
11.11.1. Diagnostic Nuclear Medicine
11.11.2. Therapeutic Nuclear Medicine
11.11.3. Brachytherapy Isotopes
11.12. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
11.13. U.S. Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
11.13.1. Diagnostic Procedures
11.13.2. Therapeutic Procedures
11.14. U.S. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
11.15. U.S. Therapeutic Nuclear Medicine Market Forecast, By Application
11.15.1. SPECT Applications
11.15.2. PET Applications
11.15.3. Therapeutic Applications
11.16. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
11.17. Canada Therapeutic Nuclear Medicine Market Forecast, By Type
11.17.1. Diagnostic Nuclear Medicine
11.17.2. Therapeutic Nuclear Medicine
11.17.3. Brachytherapy Isotopes
11.18. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
11.19. Canada Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
11.19.1. Diagnostic Procedures
11.19.2. Therapeutic Procedures
11.20. Canada Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
11.21. Canada Therapeutic Nuclear Medicine Market Forecast, By Application
11.21.1. SPECT Applications
11.21.2. PET Applications
11.21.3. Therapeutic Applications
11.22. PEST Analysis
11.23. Key Trends
11.24. Key Developments
12. Europe Therapeutic Nuclear Medicine Market Analysis
12.1. Key Findings
12.2. Europe Therapeutic Nuclear Medicine Market Overview
12.3. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.4. Europe Therapeutic Nuclear Medicine Market Forecast, By Type
12.4.1. Diagnostic Nuclear Medicine
12.4.2. Therapeutic Nuclear Medicine
12.4.3. Brachytherapy Isotopes
12.5. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.6. Europe Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.6.1. Diagnostic Procedures
12.6.2. Therapeutic Procedures
12.7. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.8. Europe Therapeutic Nuclear Medicine Market Forecast, By Application
12.8.1. SPECT Applications
12.8.2. PET Applications
12.8.3. Therapeutic Applications
12.9. Europe Therapeutic Nuclear Medicine Market Value Share Analysis, by Country
12.9.1. U.K.
12.9.2. Germany
12.9.3. France
12.9.4. Italy
12.9.5. Spain
12.9.6. Rest of Europe
12.10. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.11. U.K. Therapeutic Nuclear Medicine Market Forecast, By Type
12.11.1. Diagnostic Nuclear Medicine
12.11.2. Therapeutic Nuclear Medicine
12.11.3. Brachytherapy Isotopes
12.12. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.13. U.K. Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.13.1. Diagnostic Procedures
12.13.2. Therapeutic Procedures
12.14. U.K. Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.15. U.K. Therapeutic Nuclear Medicine Market Forecast, By Application
12.15.1. SPECT Applications
12.15.2. PET Applications
12.15.3. Therapeutic Applications
12.16. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.17. Germany Therapeutic Nuclear Medicine Market Forecast, By Type
12.17.1. Diagnostic Nuclear Medicine
12.17.2. Therapeutic Nuclear Medicine
12.17.3. Brachytherapy Isotopes
12.18. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.19. Germany Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.19.1. Diagnostic Procedures
12.19.2. Therapeutic Procedures
12.20. Germany Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.21. Germany Therapeutic Nuclear Medicine Market Forecast, By Application
12.21.1. SPECT Applications
12.21.2. PET Applications
12.21.3. Therapeutic Applications
12.22. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.23. France Therapeutic Nuclear Medicine Market Forecast, By Type
12.23.1. Diagnostic Nuclear Medicine
12.23.2. Therapeutic Nuclear Medicine
12.23.3. Brachytherapy Isotopes
12.24. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.25. France Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.25.1. Diagnostic Procedures
12.25.2. Therapeutic Procedures
12.26. France Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.27. France Therapeutic Nuclear Medicine Market Forecast, By Application
12.27.1. SPECT Applications
12.27.2. PET Applications
12.27.3. Therapeutic Applications
12.28. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.29. Italy Therapeutic Nuclear Medicine Market Forecast, By Type
12.29.1. Diagnostic Nuclear Medicine
12.29.2. Therapeutic Nuclear Medicine
12.29.3. Brachytherapy Isotopes
12.30. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.31. Italy Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.31.1. Diagnostic Procedures
12.31.2. Therapeutic Procedures
12.32. Italy Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.33. Italy Therapeutic Nuclear Medicine Market Forecast, By Application
12.33.1. SPECT Applications
12.33.2. PET Applications
12.33.3. Therapeutic Applications
12.34. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.35. Spain Therapeutic Nuclear Medicine Market Forecast, By Type
12.35.1. Diagnostic Nuclear Medicine
12.35.2. Therapeutic Nuclear Medicine
12.35.3. Brachytherapy Isotopes
12.36. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.37. Spain Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.37.1. Diagnostic Procedures
12.37.2. Therapeutic Procedures
12.38. Spain Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.39. Spain Therapeutic Nuclear Medicine Market Forecast, By Application
12.39.1. SPECT Applications
12.39.2. PET Applications
12.39.3. Therapeutic Applications
12.40. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
12.41. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Type
12.41.1. Diagnostic Nuclear Medicine
12.41.2. Therapeutic Nuclear Medicine
12.41.3. Brachytherapy Isotopes
12.42. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
12.43. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
12.43.1. Diagnostic Procedures
12.43.2. Therapeutic Procedures
12.44. Rest of Europe Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
12.45. Rest of Europe Therapeutic Nuclear Medicine Market Forecast, By Application
12.45.1. SPECT Applications
12.45.2. PET Applications
12.45.3. Therapeutic Applications
12.46. PEST Analysis
12.47. Key Trends
12.48. Key Developments
13. Asia Pacific Therapeutic Nuclear Medicine Market Analysis
13.1. Key Findings
13.2. Asia Pacific Therapeutic Nuclear Medicine Market Overview
13.3. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.4. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Type
13.4.1. Diagnostic Nuclear Medicine
13.4.2. Therapeutic Nuclear Medicine
13.4.3. Brachytherapy Isotopes
13.5. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.6. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.6.1. Diagnostic Procedures
13.6.2. Therapeutic Procedures
13.7. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.8. Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Application
13.8.1. SPECT Applications
13.8.2. PET Applications
13.8.3. Therapeutic Applications
13.9. Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, by Country
13.9.1. China
13.9.2. India
13.9.3. Japan
13.9.4. ASEAN
13.9.5. Rest of Asia Pacific
13.10. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.11. China Therapeutic Nuclear Medicine Market Forecast, By Type
13.11.1. Diagnostic Nuclear Medicine
13.11.2. Therapeutic Nuclear Medicine
13.11.3. Brachytherapy Isotopes
13.12. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.13. China Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.13.1. Diagnostic Procedures
13.13.2. Therapeutic Procedures
13.14. China Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.15. China Therapeutic Nuclear Medicine Market Forecast, By Application
13.15.1. SPECT Applications
13.15.2. PET Applications
13.15.3. Therapeutic Applications
13.16. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.17. India Therapeutic Nuclear Medicine Market Forecast, By Type
13.17.1. Diagnostic Nuclear Medicine
13.17.2. Therapeutic Nuclear Medicine
13.17.3. Brachytherapy Isotopes
13.18. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.19. India Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.19.1. Diagnostic Procedures
13.19.2. Therapeutic Procedures
13.20. India Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.21. India Therapeutic Nuclear Medicine Market Forecast, By Application
13.21.1. SPECT Applications
13.21.2. PET Applications
13.21.3. Therapeutic Applications
13.22. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.23. Japan Therapeutic Nuclear Medicine Market Forecast, By Type
13.23.1. Diagnostic Nuclear Medicine
13.23.2. Therapeutic Nuclear Medicine
13.23.3. Brachytherapy Isotopes
13.24. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.25. Japan Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.25.1. Diagnostic Procedures
13.25.2. Therapeutic Procedures
13.26. Japan Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.27. Japan Therapeutic Nuclear Medicine Market Forecast, By Application
13.27.1. SPECT Applications
13.27.2. PET Applications
13.27.3. Therapeutic Applications
13.28. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.29. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Type
13.29.1. Diagnostic Nuclear Medicine
13.29.2. Therapeutic Nuclear Medicine
13.29.3. Brachytherapy Isotopes
13.30. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.31. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.31.1. Diagnostic Procedures
13.31.2. Therapeutic Procedures
13.32. ASEAN Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.33. ASEAN Therapeutic Nuclear Medicine Market Forecast, By Application
13.33.1. SPECT Applications
13.33.2. PET Applications
13.33.3. Therapeutic Applications
13.34. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
13.35. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Type
13.35.1. Diagnostic Nuclear Medicine
13.35.2. Therapeutic Nuclear Medicine
13.35.3. Brachytherapy Isotopes
13.36. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
13.37. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
13.37.1. Diagnostic Procedures
13.37.2. Therapeutic Procedures
13.38. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
13.39. Rest of Asia Pacific Therapeutic Nuclear Medicine Market Forecast, By Application
13.39.1. SPECT Applications
13.39.2. PET Applications
13.39.3. Therapeutic Applications
13.40. PEST Analysis
13.41. Key Trends
13.42. Key Developments
14. Middle East and Africa Therapeutic Nuclear Medicine Market Analysis
14.1. Key Findings
14.2. Middle East and Africa Therapeutic Nuclear Medicine Market Overview
14.3. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
14.4. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Type
14.4.1. Diagnostic Nuclear Medicine
14.4.2. Therapeutic Nuclear Medicine
14.4.3. Brachytherapy Isotopes
14.5. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
14.6. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
14.6.1. Diagnostic Procedures
14.6.2. Therapeutic Procedures
14.7. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
14.8. Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Application
14.8.1. SPECT Applications
14.8.2. PET Applications
14.8.3. Therapeutic Applications
14.9. Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, by Country
14.9.1. GCC
14.9.2. South Africa
14.9.3. Rest of Middle East and Africa
14.10. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
14.11. GCC Therapeutic Nuclear Medicine Market Forecast, By Type
14.11.1. Diagnostic Nuclear Medicine
14.11.2. Therapeutic Nuclear Medicine
14.11.3. Brachytherapy Isotopes
14.12. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
14.13. GCC Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
14.13.1. Diagnostic Procedures
14.13.2. Therapeutic Procedures
14.14. GCC Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
14.15. GCC Therapeutic Nuclear Medicine Market Forecast, By Application
14.15.1. SPECT Applications
14.15.2. PET Applications
14.15.3. Therapeutic Applications
14.16. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
14.17. South Africa Therapeutic Nuclear Medicine Market Forecast, By Type
14.17.1. Diagnostic Nuclear Medicine
14.17.2. Therapeutic Nuclear Medicine
14.17.3. Brachytherapy Isotopes
14.18. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
14.19. South Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
14.19.1. Diagnostic Procedures
14.19.2. Therapeutic Procedures
14.20. South Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
14.21. South Africa Therapeutic Nuclear Medicine Market Forecast, By Application
14.21.1. SPECT Applications
14.21.2. PET Applications
14.21.3. Therapeutic Applications
14.22. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
14.23. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Type
14.23.1. Diagnostic Nuclear Medicine
14.23.2. Therapeutic Nuclear Medicine
14.23.3. Brachytherapy Isotopes
14.24. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
14.25. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
14.25.1. Diagnostic Procedures
14.25.2. Therapeutic Procedures
14.26. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
14.27. Rest of Middle East and Africa Therapeutic Nuclear Medicine Market Forecast, By Application
14.27.1. SPECT Applications
14.27.2. PET Applications
14.27.3. Therapeutic Applications
14.28. PEST Analysis
14.29. Key Trends
14.30. Key Developments
15. South America Therapeutic Nuclear Medicine Market Analysis
15.1. Key Findings
15.2. South America Therapeutic Nuclear Medicine Market Overview
15.3. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
15.4. South America Therapeutic Nuclear Medicine Market Forecast, By Type
15.4.1. Diagnostic Nuclear Medicine
15.4.2. Therapeutic Nuclear Medicine
15.4.3. Brachytherapy Isotopes
15.5. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
15.6. South America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
15.6.1. Diagnostic Procedures
15.6.2. Therapeutic Procedures
15.7. South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
15.8. South America Therapeutic Nuclear Medicine Market Forecast, By Application
15.8.1. SPECT Applications
15.8.2. PET Applications
15.8.3. Therapeutic Applications
15.9. South America Therapeutic Nuclear Medicine Market Value Share Analysis, by Country
15.9.1. Brazil
15.9.2. Mexico
15.9.3. Rest of South America
15.10. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
15.11. Brazil Therapeutic Nuclear Medicine Market Forecast, By Type
15.11.1. Diagnostic Nuclear Medicine
15.11.2. Therapeutic Nuclear Medicine
15.11.3. Brachytherapy Isotopes
15.12. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
15.13. Brazil Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
15.13.1. Diagnostic Procedures
15.13.2. Therapeutic Procedures
15.14. Brazil Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
15.15. Brazil Therapeutic Nuclear Medicine Market Forecast, By Application
15.15.1. SPECT Applications
15.15.2. PET Applications
15.15.3. Therapeutic Applications
15.16. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
15.17. Mexico Therapeutic Nuclear Medicine Market Forecast, By Type
15.17.1. Diagnostic Nuclear Medicine
15.17.2. Therapeutic Nuclear Medicine
15.17.3. Brachytherapy Isotopes
15.18. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
15.19. Mexico Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
15.19.1. Diagnostic Procedures
15.19.2. Therapeutic Procedures
15.20. Mexico Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
15.21. Mexico Therapeutic Nuclear Medicine Market Forecast, By Application
15.21.1. SPECT Applications
15.21.2. PET Applications
15.21.3. Therapeutic Applications
15.22. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Type
15.23. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Type
15.23.1. Diagnostic Nuclear Medicine
15.23.2. Therapeutic Nuclear Medicine
15.23.3. Brachytherapy Isotopes
15.24. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Procedural Volume Assessment
15.25. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Procedural Volume Assessment
15.25.1. Diagnostic Procedures
15.25.2. Therapeutic Procedures
15.26. Rest of South America Therapeutic Nuclear Medicine Market Value Share Analysis, By Application
15.27. Rest of South America Therapeutic Nuclear Medicine Market Forecast, By Application
15.27.1. SPECT Applications
15.27.2. PET Applications
15.27.3. Therapeutic Applications
15.28. PEST Analysis
15.29. Key Trends
15.30. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. Cardinal Health
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. GE Healthcare
16.3.3. Curium
16.3.4. Lantheus Medical Imaging
16.3.5. Bayer AG
16.3.6. Bracco Imaging
16.3.7. Eczacýbaþý-Monrol Nuclear Products (Turkey)
16.3.8. Nordion (Canada)
16.3.9. Advanced Accelerator Applications (France)
16.3.10. NTP Radioisotopes (South Africa)
16.3.11. JSC Isotope (Russia)
16.3.12. NorthStar Medical Radioisotopes (US)
16.3.13. Eckert & Ziegler (Germany)
16.3.14. Jubilant DraxImage (Canada)
16.3.15. PharmaLogic (US)
16.3.16. Institute of Isotopes Co., Ltd. (Hungary)
16.3.17. Sinotau Pharmaceuticals (China)
16.3.18. Isotopia Molecular Imaging Limited (Israel)
16.3.19. SHINE Medical Technologies (US)
16.3.20. Global Medical Solutions (US)